Author: gemmaharless
Alvotech Completes Second Round of a US$100 Million Private Placement
Multinational biopharmaceutical company Alvotech has successfully completed a second round of its US$100 million private placement, for US$35 million. The first round which was completed in October 2020, amounted to US$65 million. As part of the first round, Shinhan from Korea, Baxter Healthcare SA from the US and ATHOS (Strungmann Family Office) from Germany invested in Alvotech. In the course of the second round, Alvotech is pleased to announce additional interest from a wider range of investors, including within Iceland and internationally. Robert Wessman, Chairman of Alvotech, said: “We are very pleased to have secured this private placement, as we ... Read more